Efficacy of a collagen-based dressing in an animal model of delayed wound healing

被引:25
作者
Guillemin, Y. [1 ]
Le Broc, D. [1 ]
Segalen, C. [1 ]
Kurkdjian, E. [1 ]
Gouze, J. N. [1 ]
机构
[1] Genbiotech, Dept Res & Dev, F-06600 Antibes, France
关键词
collagen-scaffold; diabetic foot ulcer; epithelialisation; matrix metalloproteinases; tissue remodelling; OXIDIZED REGENERATED CELLULOSE/COLLAGEN; TISSUE INHIBITOR; FOOT ULCERS; IN-VITRO; MATRIX-METALLOPROTEINASE-9; MATRIX; REPAIR; GROWTH; EXPRESSION; ULCERATION;
D O I
10.12968/jowc.2016.25.7.406
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100227 [皮肤病学];
摘要
Objective: The aim of this study was to evaluate in vitro and in vivo the efficacy of GBT013, a collagen-based dressing, for the treatment of chronic wounds, in a db/db mouse model of diabetes. Method: Macroscopic and histologic analyses of db/db mice wound healing with GBT013 or saline gauze were assessed. The mRNA expression and the proliferation of dermal fibroblast were investigated. Matrix metalloproteinases (MMP)-2 and MMP-9 activities were quantified. Results: In db/db mice, GBT013 improves wound epithelialisation when compared with saline gauze. Histological analysis of scar tissue also shows an enhancement of remodelling associated with no sign of acute inflammation. In addition, GBT013 significantly decreases interleukin (IL)-6 and IL-8, significantly increases tissue inhibitors of metalloproteinases (TIMP)-1 and TIMP-2 fibroblast mRNA expression and significantly reduces in vitro MMP-2 and MMP-9 enzymatic activities. Moreover, GBT013 allows cell growth inside the matrix and stimulates proliferation of human dermal fibroblast. Conclusion: By contributing to restore MMPs/TIMPs balance, GBT013 may function in all key stages of wound healing, such as inflammation, proliferation and tissue remodelling, and ultimately may provide a favourable environment for skin repair.
引用
收藏
页码:406 / 413
页数:7
相关论文
共 35 条
[1]
Glycosaminoglycan affinity of the complete fibroblast growth factor family [J].
Asada, Masahiro ;
Shinomiya, Michiyo ;
Suzuki, Masashi ;
Honda, Emi ;
Sugimoto, Rika ;
Ikekita, Masahiko ;
Imamura, Toru .
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 2009, 1790 (01) :40-48
[2]
Boulton AJM, 2008, DIABETES CARE, V31, P1679, DOI 10.2337/dc08-9021
[3]
Diabetic Foot Ulcer: An Evidence-Based Treatment Update [J].
Braun, Liza R. ;
Fisk, Whitney A. ;
Lev-Tov, Hadar ;
Kirsner, Robert S. ;
Isseroff, Roslyn R. .
AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2014, 15 (03) :267-281
[4]
Recent insights into the causes of chronic leg ulceration in venous diseases and implications other types of chronic wounds [J].
Chen, W. Y. John ;
Rogers, Alan A. .
WOUND REPAIR AND REGENERATION, 2007, 15 (04) :434-449
[5]
Cell contraction forces in scaffolds with varying pore size and cell density [J].
Corin, Karolina A. ;
Gibson, Lorna J. .
BIOMATERIALS, 2010, 31 (18) :4835-4845
[6]
The role of oxidised regenerated cellulose/collagen in chronic wound repair and its potential mechanism of action [J].
Cullen, B ;
Watt, PW ;
Lundqvist, C ;
Silcock, D ;
Schmidt, RJ ;
Bogan, D ;
Light, ND .
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2002, 34 (12) :1544-1556
[7]
Emerging chitin and chitosan nanofibrous materials for biomedical applications [J].
Ding, Fuyuan ;
Deng, Hongbing ;
Du, Yumin ;
Shi, Xiaowen ;
Wang, Qun .
NANOSCALE, 2014, 6 (16) :9477-9493
[8]
Accelerated wound closure in neutrophil-depleted mice [J].
Dovi, JV ;
He, LK ;
DiPietro, LA .
JOURNAL OF LEUKOCYTE BIOLOGY, 2003, 73 (04) :448-455
[9]
Treatment of chronic wounds: State of the art and future concepts [J].
Eming, SA ;
Smola, H ;
Krieg, T .
CELLS TISSUES ORGANS, 2002, 172 (02) :105-117
[10]
Froget S, 2003, EUR CYTOKINE NETW, V14, P60